Literature DB >> 27813339

Metabolic support for the heart: complementary therapy for heart failure?

Ward A Heggermont1,2,3, Anna-Pia Papageorgiou1,2, Stephane Heymans1,2, Marc van Bilsen2.   

Abstract

The failing heart has an increased metabolic demand and at the same time suffers from impaired energy efficiency, which is a detrimental combination. Therefore, therapies targeting the energy-deprived failing heart and rewiring cardiac metabolism are of great potential, but are lacking in daily clinical practice. Metabolic impairment in heart failure patients has been well characterized for patients with reduced ejection fraction, and is coming of age in patients with 'preserved' ejection fraction. Targeting cardiomyocyte metabolism in heart failure could complement current heart failure treatments that do improve cardiovascular haemodynamics, but not the energetic status of the heart. In this review, we discuss the hallmarks of normal cardiac metabolism, typical metabolic disturbances in heart failure, and past and present therapeutic targets that impact on cardiac metabolism.
© 2016 The Authors. European Journal of Heart Failure © 2016 European Society of Cardiology.

Entities:  

Keywords:  Cardiac metabolism; Energy starvation; Foetal switch; Heart failure; Metabolic therapy

Mesh:

Substances:

Year:  2016        PMID: 27813339     DOI: 10.1002/ejhf.678

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  28 in total

Review 1.  Recent updates on novel therapeutic targets of cardiovascular diseases.

Authors:  Muhammad Afzal
Journal:  Mol Cell Biochem       Date:  2020-08-26       Impact factor: 3.396

2.  AMPK Prevents Palmitic Acid-Induced Apoptosis and Lipid Accumulation in Cardiomyocytes.

Authors:  Lucas Adrian; Matthias Lenski; Klaus Tödter; Jörg Heeren; Michael Böhm; Ulrich Laufs
Journal:  Lipids       Date:  2017-08-20       Impact factor: 1.880

3.  Cardioprotective effects of Qishen Granule () on sarcoplasmic reticulum Ca2+ handling in heart failure rats.

Authors:  Ling-Hui Lu; Chun Li; Qi-Yan Wang; Qian Zhang; Yi Zhang; Hui Meng; Yong Wang; Wei Wang
Journal:  Chin J Integr Med       Date:  2017-05-11       Impact factor: 1.978

4.  Metabolic remodeling of substrate utilization during heart failure progression.

Authors:  Liang Chen; Jiangping Song; Shengshou Hu
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

5.  Experimental Evaluation of Anxiolytic and Analgesic Properties of a New Linear Methoxyphenyltriazaalkane Derivative with Cardiotropic Activity.

Authors:  L G Kolik; A V Nadorova; I B Tsorin; V V Barchukov; G V Mokrov; A M Likhosherstov; T A Gudasheva; S A Kryzhanovskii; A D Durnev
Journal:  Bull Exp Biol Med       Date:  2021-04-24       Impact factor: 0.804

6.  Adropin treatment restores cardiac glucose oxidation in pre-diabetic obese mice.

Authors:  Dharendra Thapa; Bingxian Xie; Manling Zhang; Michael W Stoner; Janet R Manning; Brydie R Huckestein; Lia R Edmunds; Steven J Mullett; Charles F McTiernan; Stacy G Wendell; Michael J Jurczak; Iain Scott
Journal:  J Mol Cell Cardiol       Date:  2019-02-26       Impact factor: 5.000

7.  Functional and Metabolic Imaging in Heart Failure with Preserved Ejection Fraction: Promises, Challenges, and Clinical Utility.

Authors:  Matthew K Burrage; Andrew J Lewis; Jack J J Miller
Journal:  Cardiovasc Drugs Ther       Date:  2022-07-26       Impact factor: 3.947

8.  Short-term administration of Nicotinamide Mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure.

Authors:  Rongli Zhang; Yuyan Shen; Lin Zhou; Panjamaporn Sangwung; Hisashi Fujioka; Lilei Zhang; Xudong Liao
Journal:  J Mol Cell Cardiol       Date:  2017-09-05       Impact factor: 5.000

Review 9.  Metabolic Modulation of Cardiac Metabolism in Heart Failure.

Authors:  Giuseppe Mc Rosano; Cristiana Vitale
Journal:  Card Fail Rev       Date:  2018-08

Review 10.  Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg.

Authors:  Daniela Miranda-Silva; Tânia Lima; Patrícia Rodrigues; Adelino Leite-Moreira; Inês Falcão-Pires
Journal:  Heart Fail Rev       Date:  2021-01-07       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.